G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

Name: G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer
Published: 2018
License: Public Domain

G1 Therapeutics, Inc. · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

breast breastcancer carcinoma er metastaticbreastcancer negative positive

carcinoma, ductal, breast, breast cancer female, breast neoplasm, breast cancer, metastatic breast cancer, advanced breast cancer, stage iv breast cancer, oral serd, serd, her2-negative, er-positive, er+

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 836730
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.